RATIONALE: Accurate mediastinal staging is a cornerstone in the management of patients with lung cancer. For patients with radiographically normal mediastinum, current lung cancer guidelines recommend invasive mediastinal staging when tumors are centrally located. However, definitions of central tumors are nonspecific, and there are discrepancies among guidelines (e.g., some use the inner one-third of the hemithorax, whereas others use the inner two-thirds). OBJECTIVES: To describe the definitions of central tumors used by pulmonologists and thoracic surgeons in their practices. METHODS: An online questionnaire was e-mailed to members of the American Association for Bronchology and Interventional Pulmonology and members of the Cardiothoracic Surgery Network. MEASUREMENTS AND MAIN RESULTS: A total of 218 participants completed our survey (12% response rate). Most common definitions for central tumors were: inner one-third of the hemithorax (55%), in contact with hilar structures (29%), and inner two-thirds of the hemithorax (15%). Of note, 29% of participants chose a definition fabricated specifically for this survey and not supported by guidelines. Regarding the method to delineate the thirds of the hemithorax, 182 (84%) participants chose a system of concentric lines arising in the hilum, whereas 31 (14%) chose straight lines in the sagittal plane of the chest. We found strikingly similar responses in members of both societies. CONCLUSIONS: A uniform definition of tumor centrality is currently lacking, and should be formulated. Studies using objective measurements that evaluate the ability of these different definitions of central lung tumors to predict N2 disease are needed to construct a clear and evidence-based definition.
RATIONALE: Accurate mediastinal staging is a cornerstone in the management of patients with lung cancer. For patients with radiographically normal mediastinum, current lung cancer guidelines recommend invasive mediastinal staging when tumors are centrally located. However, definitions of central tumors are nonspecific, and there are discrepancies among guidelines (e.g., some use the inner one-third of the hemithorax, whereas others use the inner two-thirds). OBJECTIVES: To describe the definitions of central tumors used by pulmonologists and thoracic surgeons in their practices. METHODS: An online questionnaire was e-mailed to members of the American Association for Bronchology and Interventional Pulmonology and members of the Cardiothoracic Surgery Network. MEASUREMENTS AND MAIN RESULTS: A total of 218 participants completed our survey (12% response rate). Most common definitions for central tumors were: inner one-third of the hemithorax (55%), in contact with hilar structures (29%), and inner two-thirds of the hemithorax (15%). Of note, 29% of participants chose a definition fabricated specifically for this survey and not supported by guidelines. Regarding the method to delineate the thirds of the hemithorax, 182 (84%) participants chose a system of concentric lines arising in the hilum, whereas 31 (14%) chose straight lines in the sagittal plane of the chest. We found strikingly similar responses in members of both societies. CONCLUSIONS: A uniform definition of tumor centrality is currently lacking, and should be formulated. Studies using objective measurements that evaluate the ability of these different definitions of central lung tumors to predict N2 disease are needed to construct a clear and evidence-based definition.
Authors: Emily A DuComb; Benjamin A Tonelli; Ya Tuo; Bernard F Cole; Vitor Mori; Jason H T Bates; George R Washko; Raúl San José Estépar; C Matthew Kinsey Journal: Chest Date: 2020-06-26 Impact factor: 9.410
Authors: Jingjing Huang; Chengyu Bian; Wenhao Zhang; Guang Mu; Zhipeng Chen; Yang Xia; Mei Yuan; Hideki Ujiie; Jean H T Daemen; Erik R de Loos; Quan Zhu; Weibing Wu; Liang Chen; Jun Wang Journal: Transl Lung Cancer Res Date: 2022-06
Authors: Ahmed Elsakka; Elena N Petre; Fourat Ridouani; Mario Ghosn; Matthew J Bott; Bryan C Husta; Maria E Arcila; Erica Alexander; Stephen B Solomon; Etay Ziv Journal: JTO Clin Res Rep Date: 2022-05-18
Authors: Gabriela Martinez-Zayas; Francisco A Almeida; Lonny Yarmus; Daniel Steinfort; Donald R Lazarus; Michael J Simoff; Timothy Saettele; Septimiu Murgu; Tarek Dammad; D Kevin Duong; Lakshmi Mudambi; Joshua J Filner; Sofia Molina; Carlos Aravena; Jeffrey Thiboutot; Asha Bonney; Adriana M Rueda; Labib G Debiane; D Kyle Hogarth; Harmeet Bedi; Mark Deffebach; Ala-Eddin S Sagar; Joseph Cicenia; Diana H Yu; Avi Cohen; Laura Frye; Horiana B Grosu; Thomas Gildea; David Feller-Kopman; Roberto F Casal; Michael Machuzak; Muhammad H Arain; Sonali Sethi; George A Eapen; Louis Lam; Carlos A Jimenez; Manuel Ribeiro; Laila Z Noor; Atul Mehta; Juhee Song; Humberto Choi; Junsheng Ma; Liang Li; David E Ost Journal: Chest Date: 2021-04-28 Impact factor: 10.262
Authors: Gabriela Martinez-Zayas; Francisco A Almeida; Michael J Simoff; Lonny Yarmus; Sofia Molina; Benjamin Young; David Feller-Kopman; Ala-Eddin S Sagar; Thomas Gildea; Labib G Debiane; Horiana B Grosu; Roberto F Casal; Muhammad H Arain; George A Eapen; Carlos A Jimenez; Laila Z Noor; Shiva Baghaie; Juhee Song; Liang Li; David E Ost Journal: Am J Respir Crit Care Med Date: 2020-01-15 Impact factor: 21.405
Authors: Yeon Wook Kim; Minhee Jeon; Myung Jin Song; Byoung Soo Kwon; Sung Yoon Lim; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Kyung Won Lee; Jae Ho Lee; Choon-Taek Lee Journal: Transl Lung Cancer Res Date: 2021-11
Authors: Diem Vuong; Marta Bogowicz; Leonard Wee; Oliver Riesterer; Eugenia Vlaskou Badra; Louisa Abigail D'Cruz; Panagiotis Balermpas; Janita E van Timmeren; Simon Burgermeister; André Dekker; Dirk De Ruysscher; Jan Unkelbach; Sandra Thierstein; Eric I Eboulet; Solange Peters; Miklos Pless; Matthias Guckenberger; Stephanie Tanadini-Lang Journal: Sci Rep Date: 2021-10-22 Impact factor: 4.379